Effects of corporate social responsibility on pharmaceutical multinational enterprises performance: Research and development and business efficiency perspectives

Fang Chen Kao and Minh‐Hieu Le

Managerial and Decision Economics, 2022, vol. 43, issue 8, 3419-3434

Abstract: This study employs an integrated two‐stage network data envelopment analysis, multiplicative efficiency aggregation in a second‐order cone programming approach, to assess efficiency scores of 41 pharmaceutical multinational enterprises (PMNEs). We also suggest a strategy for efficiently forecasting each PMNE's future efficiency score using a trend analysis technique. In particular, this study investigates how the three dimensions of corporate social responsibility (CSR) affect R&D efficiency and business efficiency. Results indicate that the governance pillar (social pillar) has a positive (negative) effect on the business efficiency of PMNEs. The findings give PMNE executives additional references to consider when deciding on CSR practices.

Date: 2022
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
https://doi.org/10.1002/mde.3605

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:wly:mgtdec:v:43:y:2022:i:8:p:3419-3434

Access Statistics for this article

Managerial and Decision Economics is currently edited by Antony Dnes

More articles in Managerial and Decision Economics from John Wiley & Sons, Ltd.
Bibliographic data for series maintained by Wiley Content Delivery ().